Table 2.

Patients per maximum toxicity grade for ≥ grade 2 treatment-related events (n = 24).

Treatment-Related Adverse Events	Grade 2 n (%)	Grade 3 n (%)	Grade 4 n (%)
Injection site reaction	2 (8%)	0	0
Hyperglycemia	2 (8%)	0	0
Hypoglycemia	1 (4%)	0	0
Thrombocytopenia	1 (4%)	0	0
Neutropenia	1 (4%)	0	0
Leukopenia	1 (4%)	0	0
Elevated alanine aminotransferase	1 (4%)	0	0
Fever	1 (4%)	0	0